Luyten and colleagues' prospective, randomized, multicenter, double-blind trial, therefore, compared continuous and intermittent celecoxib for the treatment of OA. All 123 patients had a flare of ...

Nearly a decade after reports first surfaced linking the prescription pain reliever celecoxib (Celebrex) to an increased risk of heart attack, and two years after the American Heart Association ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Neurosense entered a binding term sheet with a global pharmaceutical company to advance development and commercialization of ...

We evaluated opioid-sparing effects and rehabilitative results after perioperative celecoxib administration for total knee arthroplasty. Methods: This was a prospective, randomized, observer-blind ...